slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Conditions of the Gastrointestinal System PowerPoint Presentation
Download Presentation
Conditions of the Gastrointestinal System

Loading in 2 Seconds...

play fullscreen
1 / 53

Conditions of the Gastrointestinal System - PowerPoint PPT Presentation


  • 581 Views
  • Uploaded on

Conditions of the Gastrointestinal System Part A: Module A2 Session 5 Objectives Describe the various infectious agents that cause chronic diarrhea Describe the clinical presentation of each infection List the recommended diagnostics and common findings for each infection

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Conditions of the Gastrointestinal System' - jaden


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Conditions of the

Gastrointestinal System

Part A: Module A2

Session 5

objectives
Objectives
  • Describe the various infectious agents that cause chronic diarrhea
  • Describe the clinical presentation of each infection
  • List the recommended diagnostics and common findings for each infection
  • Understand the treatment and management of chronic diarrhea
  • Discuss hepatitis, including management, treatment, and prevention
  • Make a differential diagnosis using a case study approach
overview
Overview
  • Chronic diarrhea is a very frequent and frustrating problem in PLHA: at least 50% experience it sometime during the evolution of the disease
  • Often accompanied by nausea, weight loss, abdominal cramps, and dehydration
  • Often an intermittent watery diarrhea, without blood or mucous
  • In one-third to two-thirds of cases, no cause is identified
  • In high HIV prevalence areas, chronic diarrhea is invariably due to symptomatic HIV infection.
slide4

Wherever possible the cause should be established and specific treatment given

  • If cause is not established, management is symptomatic: giving anti-diarrheals such as codeine phosphate
  • The key to good management is rehydration without much sugar, and including potassium
  • High energy and protein intake reduces the degree of muscle wasting
  • Prevention consists of: attention to personal hygiene (hand-washing), drinking boiled water, and eating only thoroughly cooked meat and vegetables
major pathogens
Major Pathogens

Bacterial infectionCampylobacter, Shigella, and Salmonella

Protozoal infection Cryptosporidium species, Giardia lamblia, Isospora belli, Entamoeba histolitica, Microsporidium species

Toxin induced E. coli and Clostridium difficile

Mycobacterial infection M. tuberculosis, M. Avium complex

Helminthic infection Strongyloides stercoralis

Fungal infection Candida species (seldom a cause of diarrhea)

bacterial infection campylobacter
Bacterial infection: Campylobacter

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Fever and general malaise, sometimes without GI symptoms
    • When present, GI symptoms include bloody diarrhea, abdominal pain and weight loss.
slide8

Campylobacter: Diagnostics

  • Campylobacter bacilli found in stool culture
slide9

Campylobacter

Management and Treatment

  • Erythromycin 500 mg bid x 5 days (1st choice)
  • Fluoroquinolones are also effective, but resistance rates of 30-50% have been reported in some developing countries
slide10

CampylobacterUnique features, Caveats

  • It is clinically impossible to distinguish the different etiological agents of bacterial gastroenteritis without a stool culture
    • If empiric therapy with TMP/SMX is not effective in patients with bacillary dysentery, try fluoroquinolones
    • If symptoms of bloody diarrhea persist , try erythromycin
bacterial infection salmonella
Bacterial infection: Salmonella

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Fever; general malaise
    • Sometimes no GI symptoms
    • If there are GI symptoms, will see:
        • Bloody diarrhea
        • Abdominal pain
        • Weight loss
bacterial infection salmonella diagnostics
Bacterial infection: SalmonellaDiagnostics
  • Stool culture
  • Salmonella bacilli may be found in stool/blood cultures
  • Serology: positive Widal test with increased titers
management and treatment
Management and Treatment
  • TMP/SMX 960 mg bid or
  • Chloramphenicol 250 mg qid for 3 weeks
  • In case of sepsis, IV therapy is necessary
  • Shorter regimens are:
    • ciprofloxacin 500 mg bid or ofloxacin 400 mg bid or ceftriaxone 2 g IV for 7-10 days
  • Many patients often relapse after treatment and chronic maintenance therapy (TMP/SMX 1 DD daily) is sometimes necessary.
unique features caveats
Unique features, Caveats
  • Salmonellosis is a frequent cause of bacteremia in PLHA
bacterial infection shigella
Bacterial infection: Shigella

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • High fever
    • Abdominal pain
    • Bloody diarrhea
slide16

ShigellaDiagnostics

  • Stool microscopy— fresh examination and after concentration
  • Multiple stool samples may be necessary
  • Shigella bacillus found in stool
shigella management and treatment
ShigellaManagement and Treatment
  • TMP/SMX 960 mg bid x 5 days

or

  • amoxicillin 500 mg tid x 5 days
  • If resistant to the above, give
    • ciprofloxacin 500 mg bid
    • or
    • norfloxacin 400 mg bid x 5 days
    • or
    • nalidixic acid 1 g qid x 10 days
unique features caveats18
Unique features, Caveats

In many developing countries resistance of Shigella

(and Salmonella) to TMP/SMX has increased.

protozoal infection clostridium difficile
Protozoal infection: Clostridium difficile

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Diarrhea
    • Fever
slide20

Clostridium difficileDiagnostics

  • Stool microscopy and culture
slide21

Clostridium difficileUnique features, caveats

  • May be underestimated as a cause of diarrhea in AIDS patients in the tropics because of the difficulty in making the diagnosis. Frequent hospitalization and exposure to antibiotics puts patients at high risk of infection
  • As in HIV-negative patients, 5-30% of patients with C. difficile-associated diarrhea experience relapse
protozoal infection cryptosporidium
Protozoal infection: Cryptosporidium

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Recent and prolonged history of severe diarrhea—usually large volume, watery stools with a lot of abdominal pain, bowel noise and activity
    • Severe weight loss/wasting in those with longer history
slide23

Cryptosporidium

Diagnostics

  • Stool samples x 3 for staining/AFB smear
  • Oocysts present in stool exam
  • No fecal WBCs
slide24

Cryptosporidium

Management and Treatment

  • Rehydration (IV and/or ORS)
  • Paromomycin 500 mg qid for 2-3 weeks; maintenance with 500 mg bid often required
  • Codeine phosphate 30-60 mg tid until under control (or other anti-diarrheal agents such as loperamide 2-4 mg tid or qid—maximum of 32 mg in 24 hours)
  • The use of ARV is protective against cryptosporidiosis
slide26

Cryptosporidium

Unique features, Caveats

  • Highly infectious
  • Transmitted through water, food, animal-to-human and human-to-human contact
      • Special precautions should be taken to prevent exposure: people with HIV and a CD4<200 should boil tap water for at least 1 minute to reduce risk of ingestion of oocysts in potentially contaminated drinking water. 
  • May be the AIDS-defining presentation in patients who previously had few symptoms of HIV infection
toxin induced e coli
Toxin induced: E. coli

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Diarrhea
    • Fever
toxin induced e coli28
Toxin induced: E. coli

Diagnostics

  • Stool microscopy and culture
entamoeba histolytica
Entamoeba histolytica

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Colitis
    • Bloody stools
    • Cramps
    • Can be asymptomatic
entamoeba histolytica30
Entamoeba histolytica

Diagnostics

  • Stool for ova and parasite exam
  • O&P present in stool exam
  • No fecal WBC’s
entamoeba histolytica management and treatment
Entamoeba histolyticaManagement and Treatment
  • metronidazole 500-700 mg po or IV tid x 5-10 days

or

  • paromomycin 500 mg po qid x 7 days
entamoeba histolytica32
Entamoeba histolytica

Unique features, Caveats

  • E. histolytica may be common in the general population in developing countries, but may be recurrent or more severe in HIV patients
giardia lamblia
Giardia lamblia

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Enteritis
    • Watery diarrhea  malabsorption
    • Bloating
    • Flatulence
giardia lamblia34
Giardia lamblia

Diagnostics

  • Stool for ova and parasites
  • O&P in stool exam
giardia lamblia35
Giardia lamblia

Management and Treatment

  • Metronidazole 250 mg po tid x 10 days
giardia lamblia36
Giardia lamblia

Unique features, Caveats

  • Common cause of diarrhea in general population, but may be recurrent or more severe in HIV patients
isospora belli
Isospora belli

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Enteritis; watery diarrhea
    • No fever
    • Wasting; malabsorption

** Symptoms similar to what occurs with Cryptosporidium

giardia lamblia diagnostics
Giardia lambliaDiagnostics
  • Stool x 3: unstained wet preparation
    • Isospora belli oocysts are relatively big (2030 m) and can be easily identified in unstained wet stool preparation
  • No fecal WBCs
giardia lamblia39
Giardia lamblia

Management and Treatment

  • Most cases are readily treated with sulfamethoxazole/ trimethoprim (960 mg qid for 10 days) followed by 1 double strength tablet (960 mg bid for 3 weeks), then chronic suppression with sulfamethoxazole/ trimethoprim (960mg daily)
  • High dose of pyrimethamine with calcium folinate to prevent myelosuppression
  • Long-term maintenance therapy may be required to prevent relapse
microsporidium
Microsporidium

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Profuse watery, non-bloody diarrhea
    • Abdominal pain and cramping
    • Nausea
    • Vomiting
    • Weight loss
giardia lamblia diagnostics42
Giardia lambliaDiagnostics
  • Fresh stool microscopy with modified trichrome stain
  • Spores present in stool exam
giardia lamblia unique features caveats
Giardia lambliaUnique features, Caveats
  • Species of microsporidia have been linked to disseminated disease, e.g., cholangitis, keratoconjunctivitis, hepatitis, peritonitis, and infections of the lungs, muscles, and brain
  • However, the presence of microsporidia does not always correlate with symptomatic disease
  • Most microsporidial infections are not treatable
helminthic infection strongyloides stercoralis
Helminthic infection: Strongyloides stercoralis

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Serpiginous erythematous skin lesions (larva currens)
    • Diarrhea
    • Abdominal pain
    • Cough
    • Full-blown hyper-infection syndrome has the characteristics of a gram-negative sepsis, with acute respiratory distress syndrome, disseminated intravascular coagulation, and secondary peritonitis, cough
strongyloides stercoralis diagnostics
Strongyloides stercoralisDiagnostics
  • Chest x-ray: The chest x-ray may reveal diffuse pulmonary infiltrates.
  • Stool microscopy, (multiple stool samples may be necessary)
  • Sputum sample
  • In disseminated strongyloidiasis, filariform larvae can be found in stool, sputum, broncho-alveolar lavage fluid, pleural fluid, peritoneal fluid and surgical drainage fluid
strongyloides stercoralis management and treatment
Strongyloides stercoralisManagement and Treatment
  • Ivermectin 12 mg daily for 3 days. This drug is also the drug of choice for the treatment of systemic strongyloidiasis
  • An alternative treatment is albendazole 400 mg bid x 5 days
  • A maintenance therapy once a month is necessary to suppress symptomatic infection (albendazole 400 mg or ivermectin 6 mg once monthly)
strongyloides stercoralis unique features caveats
Strongyloides stercoralisUnique features, Caveats
  • In immuno-compromised patients, strongyloides can cause overwhelming infection.This serious complication is called strongyloides hyper-infection syndrome and has a high case-fatality rate
  • Disseminated strongyloidiasis and heavy worm loads can occur in patients with HIV, but the full-blown hyper-infection syndrome is less common
  • The likelihood of developing the hyper-infection syndrome is also increased in patients taking high-dose steroids
other hepatitis
Other: Hepatitis

Presenting Signs and Symptoms

  • Clinical Symptoms may evolve
    • Flu-like symptoms of lassitude, weakness, drowsiness, anorexia, nausea, abdominal discomfort, fever, headache, jaundice (including dark urine, gray stools, and mild pruritis),
    • Hepatomegaly
hepatitis management and treatment
HepatitisManagement and Treatment
  • Symptomatic and supportive care. Where available, Interferon for treatment of Hepatitis B and C and Havrix as a preventive measure for patients at risk for hepatitis A; Interferon for treatment of Hepatitis B and C. Epivir-HBV for

Hep B

  • Alcohol consumption should be discouraged during convalescence
hepatitis prevention
HepatitisPrevention
  • Frequent hand-washing and good hygiene are important as Hepatitis A is spread by oral-fecal route and often by food contamination
  • Hepatitis B and C are transmitted through contact with blood or through sexual contact
  • Condoms can reduce risk of transmission
  • It is important to discourage needle sharing
comments
Comments
  • Vaccines are very expensive and may not be available
  • Co-infection of HIV and Hepatitis C signifies probability of acceleration of HIV disease and Hepatitis C disease
  • The hepatotoxic effect of some ARVs (e.g., Nevirapine) and other drugs (e.g., Ketoconazole) is significant